Diana S. Wolfe

Dr. Diana S. Wolfe

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
DWDiana S. Wolfe
Diana S. Wolfe
AHAfshan B. Hameed
Afshan B. Hameed
CTCynthia C. Taub
Cynthia C. Taub
AZAli N. Zaidi
Ali N. Zaidi
ABAnna E. Bortnick
Anna E. Bortnick

1 December 2021 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
SWSara L. Wiener
Sara L. Wiener
DWDiana S. Wolfe
Diana S. Wolfe

Verified
Journal Article
Open access
PDF file
DWDiana S. Wolfe
Diana S. Wolfe
CLChristina Liu
Christina Liu
JAJACK ALBOUCAI
JACK ALBOUCAI
AKAriel Karten
Ariel Karten
JMJuliet Mushi
Juliet Mushi
ABAnna E. Bortnick
Anna E. Bortnick
Peripartum cardiomyopathy (PPCM) is idiopathic systolic congestive heart failure around pregnancy. Comparisons with matched controls are lacking. We investigated maternal characteristics and outcomes up to 12 months in a cohort admitted to Montefiore Health System in Bronx, New York 1999–2015 (n = 53 cases and n = 92 age and race-matched controls, >80% Black or Hispanic/Latina). Compared to peers, women with PPCM had more chronic hypertension (24.5% vs. 8.8%, p = 0.001), prior gestational hypertension (20.8% vs. 5.4%, p = 0.001), prior preeclampsia (17.0% vs. 3.3%, p = 0.001), familial dilated cardiomyopathy (5.7% vs. 0.0%, p = 0.04), smoking (15.1% vs. 2.2%, p = 0.001), lower summary socioeconomic scores (−4.12 (IQR −6.81, −2.13) vs. −1.62 (IQR −4.20, −0.74), p < 0.001), public insurance (67.9% vs. 29.3% p = 0.001), and frequent depressive symptoms. Women with PPCM were often admitted antepartum (34.0% vs. 18.5%, p = 0.001) and underwent Cesarean section (65.4% vs. 30.4%, p = 0.001), but had less preterm labor (27.3% vs. 51.1%, p = 0.001). Women were rarely treated with bromocriptine (3.8%), frequently underwent left ventricular assist device placement (9.4% and n = 2 with menorrhagia requiring transfusion and progesterone) or heart transplantation (3.8%), but there were no in-hospital deaths. In sum, women with PPCM had worse socioeconomic disadvantage and baseline health than matched peers. Programs addressing social determinants of health may be important for women at high risk of PPCM.

Verified
Journal Article
Open access
PDF file
YDYasmeen Daraz
Yasmeen Daraz
SMSandhya Murthy
Sandhya Murthy
DWDiana S. Wolfe
Diana S. Wolfe
Pulmonary arterial hypertension (PAH), a female predominant disease, carries a high maternal and fetal mortality in pregnancy despite improved insight and the development of novel therapies. The high risk is attributed to the adaptive changes that take place to promote healthy fetal development during pregnancy, which can adversely affect the already compromised right ventricle in patients with PAH. While in the prior era emphasis was placed on termination of pregnancy, here we will illustrate through a multidisciplinary approach and meticulous planning at an expert center, these high-risk women can undergo successful childbirth.

29 July 2020 in Clinical Obstetrics and Gynecology
Verified
Journal Article
Closed access
DWDiana S. Wolfe
Diana S. Wolfe
The pregnant cardiac patient has become a national focus in the United States during the 21st century. Maternal mortality in the United States is on the rise, cardiac disease in pregnancy has been identified as the number one indirect cause and has driven the increase in maternal death rate greatly. This may be explained by the increasing number of women with congenital heart disease reaching reproductive age and a higher prevalence of chronic medical diseases. A triad solution includes cardiovascular screening, patient education and a multidisciplinary team. The Cardio Obstetric team is described here.

Verified
Journal Article
Open access
PDF file
NBNeha Bansal
Neha Bansal
CHCarol Fernandez Hazim
Carol Fernandez Hazim
SBSergio Badillo
Sergio Badillo
SSSharvari Shyam
Sharvari Shyam
DWDiana S. Wolfe
Diana S. Wolfe
LZLili Zhang
Lili Zhang
This review focuses on the maternal cardiovascular risk and outcomes of pregnancy in childhood, adolescent, and young adult cancer survivors who are achieving survival to their prime reproductive years. Childhood, adolescent, and young adult cancer survivors are a growing population and have increasing needs for reproductive care over decades of life. Female cancer survivors have an overall higher risk of maternal cardiovascular events compared to those without a history of cancer. In female cancer survivors with normal cardiac function before pregnancy, the incidence of new heart failure during pregnancy is low. In survivors with cardiotoxicity prior to pregnancy, the risk of heart failure during and immediately after pregnancy is much higher. We recommend cardiomyopathy surveillance with echocardiography before pregnancy for all female survivors treated with anthracyclines and chest radiation. Survivors with cardiotoxicity prior to pregnancy should be cared for by an expert multidisciplinary team, including obstetrics, cardiology, anesthesia, and specialized nursing, among others.